In February of 2009, the FDA issued a warning against long-term use of the drug Reglan (metoclopramide) because of its link to a neurological disorder, tardive dyskenesia. The FDA also required the manufacturers of Reglan to strengthen the label and include a boxed warning about its adverse side effects and the potential risk of developing this neurological disorder.

Tardive dyslenesia causes uncontrollable and repetitive movements of the body, face, and limbs. This disorder is rarely reversible, but the symptoms may decrease once Reglan use has stopped. The Reglan users who are at the greatest risk for tardive dyskenesia are elderly people, especially women, and those that have been using the drug for a long period of time.

Reglan is used to treat gastrointestinal disorders such as GERD in those people who have not responded to other forms of treatment. It is also used to treat diabetic gastroparesis, a condition in which the stomach slowly empties its contents into the intestines.  It is recommended for use by adults only and has been approved for short-term use, no longer than three months.

Many people across America are filing lawsuits against the manufacturers of Reglan for its adverse side effects. If you believe you or someone you know has been negatively affected by use of this drug, contact our Reglan litigation attorneys today.